Prevalencia de factores de riesgo cardiovascular en una población peruana de pacientes con infección por el virus de inmunodeficiencia humana en terapia antiretroviral de gran actividad

Rodriguez, Germán Valenzuela; Urbina, Fernando Mendo; Gambirazzio, Miguel Espichan
January 2007
Revista Médica Herediana;ene-mar2007, Vol. 18 Issue 1, p10
Academic Journal
Objective: To evaluate the prevalence of cardiovascular risk factors in a peruvian cohort of patients with HIV in HAART. Material and methods: We undertook an observational study between January and April 2006, in ambulatory patients of Hospital Rebagliati-ESSALUD-Perú. Results: In 276 patients, we found a prevalence of cardiovascular risk factors as follows: Hypertension in 3.26%, diabetes in 1.81%, dyslipidaemia in 34.05%, smoking in 3.96% and obesity in 4.71%. In patients who had received protease inhibitors levels of total cholesterol and triglycerides were higher (p NS). 4.16% of this population had a high score of cardiovascular risk according with Framinghan tables. Conclusions: The prevalence of cardiovascular risk factor in our cohort was low with exception of the prevalence of dyslipidaemia that was high, and there were found higher levels of total cholesterol and triglycerides in the subpopulation of patients who receive protease inhibitors.


Related Articles

  • Riesgo cardiovascular en pacientes con VIH. Castro Sansores, Carlos; Santos Rivero, Adri�n; Guerrero Flores, Alejandro; Rodr�guez S�nchez, Rusell; A. G�ngora Biachi, Renan; Bola�os Caldelas, Espiridi�n; Valencia Serrano, Nicol�s; Sarmiento Couti�o, Carlos; Castelo Navarrete, �ngel // Medicina Interna de Mexico;jul/ago2008, Vol. 24 Issue 4, p284 

    Background: Antiretroviral therapy in HIV patients has caused lipid and glucose metabolism alterations. Objective: To compare prevalence of cardiovascular risk at 10 years over 10%, in a group of HIV-infected patients with HAART, and another without HAART. Patients and methods: A...

  • Triglyceride and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease risk factors in Chinese Han children. Zhu, Wei; Liang, Li; Wang, Chun; Fu, Jun // Indian Pediatrics;Apr2013, Vol. 50 Issue 4, p394 

    Objective: To investigate the role of serum cholesterol and triglyceride in the assessment of cardiovascular disease risk factors in children and adolescents. Design: Case-control study. Setting: Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China. Subjects: Children...

  • Safety, Efficacy and Development of Resistance under the New Protease Inhibitor Lopinavir/Ritonavir: 48-Week Results. Voigt, E.; Wasmuth, J.-C.; Vogel, M.; Rockstroh, J.-K.; Kaiser, R.; Mauss, S.; Schmutz, G. // Infection;Apr2004, Vol. 32 Issue 2, p82 

    Background: Within this open-label, uncontrolled prospective trial we evaluated safety, efficacy and development of genotypic resistance under the new protease inhibitor lopinavir/ritonavir (LPV/r) in antiretroviral (ARV) HIV patients. Patients and Methods: 58 patients with virological failure...

  • Target cardiovascular risk rather than cholesterol concentration. Krumholz, Harlan M. // BMJ: British Medical Journal;12/7/2013, Vol. 347 Issue 7936, p7 

    The author discusses the Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults, issued by the American College of Cardiology and the American Heart Association in 2013. He reports on how it focused more on risk reduction rather than targeting...

  • Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose. Liu, Jian; Joshi, Divya; Sempos, Christopher T. // Applied Physiology, Nutrition & Metabolism;Apr2009, Vol. 34 Issue 2, p136 

    To evaluate how non-high-density-lipoprotein (non-HDL) is associated with impaired fasting glucose (IFG) and clustered metabolic risk (MR) factors among adolescents, we pooled 2764 adolescents, aged 12-19 years, from the National Health and Nutrition Examination Survey from 3 time periods...

  • Independent Nurse: Clinical - Optimising lipid levels. Cox, Beverley // GP: General Practitioner;2/5/2010, p19 

    The article presents information on controlling lipid levels. High lipid levels may increase the risks for cardiovascular diseases. Statins are the most commonly used pharmacological agent for patients with elevated lipid levels. It is also important to identify the factors responsible for...

  • Attitudes Toward HIV Protease Inhibitors and Medication Adherence in an Inner City HIV Population. Demmer, Craig // AIDS Patient Care & STDs;Nov2003, Vol. 17 Issue 11, p575 

    The objective of this pilot study was to examine attitudes toward protease inhibitors (PIs) among HIV-infected individuals and to assess the relationship between PI attitudes and adherence to PIs. Respondents were recruited from four AIDS service organizations in New York City; the total sample...

  • A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Kaan Okyay; Akif Balcioglu; Yusuf Tavil; Gulten Tacoy; Sedat Turkoglu; Adnan Abacı // International Journal of Cardiovascular Imaging;Aug2008, Vol. 24 Issue 6, p577 

    Abstract   Background Visceral adipose tissue plays a central role in the development of metabolic syndrome (MS). Our study aimed to determine a relationship between MS and subepicardial adipose tissue (SAT), a component of visceral fat surrounding the heart and coronary vessels. Methods A...

  • Effects of Carnitine and Coenzyme Q10 on Lipid Profile and Serum Levels of Lipoprotein(a) in Maintenance Hemodialysis Patients on Statin Therapy. Shojaei, Mirhatef; Djalali, Mahmoud; Khatami, Mohammadreza; Siassi, Fereydoun; Eshraghian, Mohammadreza // Iranian Journal of Kidney Diseases;Mar2011, Vol. 5 Issue 2, p114 

    Introduction. Dyslipidemia and high serum lipoprotein(a) are among the risk factors for cardiovascular diseases in hemodialysis patients. Statins as a first line of therapy in hyperlipidemia does not always reduce the serum lipoprotein(a) level. Several studies have reported the lipid-lowering...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics